Toinv... Results reached in BOM. 

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8609701/

Epigenetic changes may contribute importantly to cognitive decline in late life including Alzheimer’s disease (AD) and vascular dementia (VaD).

Conclusion:

"In this randomized controlled study, apabetalone was associated with improved cognition as measured by MoCA scores in those with baseline scores of 21 or less. (P=0.02) BET protein inhibitors warrant further investigation for late life cognitive disorders." (bolding added)